Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Geer MI"'
Autor:
Ganie MA; Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India.; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Rashid A; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Baba MS; Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Zargar MA; Department of Life Sciences, Central University of Kashmir, Ganderbal, India., Wani IA; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Nisar S; Department of Medicine, Government Medical College, Srinagar, India., Wani IA; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Douhath S; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Sriwastawa M; Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA., Geer MI; Department of Pharmacology, University of Kashmir, Srinagar, India., Asrar MM; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Kutum R; Department of Computer Science, Ashoka University, Sonepath, India.; Department of Computer Science, Trivedi School of Biosciences, Ashoka University, Sonepath, India., Hassan S; Department of Biotechnology, School of Bio and Chemical Engineering, Sathyabama Institute of Science and Technology (Deemed University), Chennai, India., Khan S; Department of Lab Medicine, AIIMS New Delhi, New Delhi, India., Rafi W; Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India., Bhat DA; Department of Clinical Biochemistry, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Showkat W; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Sahar T; Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Choh NA; Department of Radiodiagnosis and Imaging, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Khurshid R; Department of Obstetrics and Gynecology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Mudassar S; Department of Clinical Biochemistry, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Shah ZA; Department of Immunology and Molecular Medicine, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Shabir I; Department of Biochemistry, Iowa State University, Ames, Iowa, USA., Sofi SA; Department of Radiodiagnosis and Imaging, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Gupta N; Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India., Hafeez I; Department of Cardiology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India., Sreenivas V; Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
Publikováno v:
Clinical endocrinology [Clin Endocrinol (Oxf)] 2023 Dec; Vol. 99 (6), pp. 566-578. Date of Electronic Publication: 2023 Sep 01.
Autor:
Bahri P; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland. priya.bahri@ema.europa.eu.; European Medicines Agency (EMA) (Coordinator of the ISoP CommSIG in Her Personal Capacity), Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands. priya.bahri@ema.europa.eu., Bowring G; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Uppsala Monitoring Centre (UMC), Uppsala, Sweden., Edwards BD; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Husoteria Ltd, Ashtead, UK., Anton C; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK., Aronson JK; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK., Caro-Rojas A; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Pontificia Universidad Javeriana, Bogotá, Colombia., Hugman BPJ; Oxford, UK., Mol PG; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Ilic K; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Takeda, Cambridge, MA, USA., Daghfous R; Tunisian National Centre of Pharmacovigilance, Tunis, Tunisia., Fermont I; Israel Society for Medication and Vaccine Safety (ERANIM), Jerusalem, Israel., Furlan G; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Pfizer s.r.l., Safety Surveillance and Risk Management, Milan, Italy., Gaissmaier W; Department of Psychology, Social Psychology and Decision Sciences, University of Konstanz, Konstanz, Germany., Geer MI; Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, India., Hartigan-Go KY; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; School of Government, Ateneo De Manila University, Quezon City, Philippines., Houÿez F; European Organisation for Rare Diseases (EURORDIS), Paris, France., Neth H; Department of Psychology, Social Psychology and Decision Sciences, University of Konstanz, Konstanz, Germany., Norgela G; Uppsala Monitoring Centre (UMC), Uppsala, Sweden., Oppamayun Y; Thai Food and Drug Administration, Health Product Vigilance Center, Bangkok, Thailand., Raynor DKT; School of Healthcare, University of Leeds, Leeds, UK., Bouhlel M; Tunisian National Centre of Pharmacovigilance, Tunis, Tunisia.; Department of Pharmacology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia., Santoro F; Uppsala Monitoring Centre (UMC), Uppsala, Sweden., Sultana J; Pharmacy Department, Mater Dei Hospital, Msida, Malta.
Publikováno v:
Drug safety [Drug Saf] 2023 Jun; Vol. 46 (6), pp. 517-532. Date of Electronic Publication: 2023 May 23.
Autor:
Geer MI; Dept. of Pharmaceutical Sciences, University of Kashmir, Srinagar, J&K, India. Electronic address: ishaqgeer@gmail.com., Koul PA; Dept. of Internal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, J&K, India., Tanki SA; Dept. of Pharmacology, MM Institute of Medical Science and Research, Mullana, Ambala, India., Shah MY; Dept. of Pharmaceutical Sciences, University of Kashmir, Srinagar, J&K, India.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2016 Sep-Oct; Vol. 81, pp. 323-34. Date of Electronic Publication: 2016 Apr 20.